Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways
出版年份 2014 全文链接
标题
Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways
作者
关键词
-
出版物
Biomed Research International
Volume 2014, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2014-09-11
DOI
10.1155/2014/761608
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways
- (2014) Arshad H. Rahmani et al. Evidence-based Complementary and Alternative Medicine
- Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
- (2014) Sahdeo Prasad et al. Cancer Research and Treatment
- Curcumin Effect on MMPs and TIMPs Genes in a Breast Cancer Cell Line
- (2013) Zeinab Korany Hassan et al. Asian Pacific Journal of Cancer Prevention
- Design andIn VitroEvaluation of a New Nano-Microparticulate System for Enhanced Aqueous-Phase Solubility of Curcumin
- (2013) Diana Guzman-Villanueva et al. Biomed Research International
- RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells
- (2012) Shadan Ali et al. CANCER LETTERS
- YAP oncogene overexpression supercharges colon cancer proliferation
- (2012) Joseph Avruch et al. CELL CYCLE
- Curcumin antifungal and antioxidant activities are increased in the presence of ascorbic acid
- (2012) Omar Arafat Kdudsi Khalil et al. FOOD CHEMISTRY
- RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
- (2012) BABASAHEB YADAV et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Innovative Preparation of Curcumin for Improved Oral Bioavailability
- (2011) Hiroki Sasaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
- (2011) Annika Gustafsson Asting et al. BMC CANCER
- Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
- (2011) L Lin et al. BRITISH JOURNAL OF CANCER
- Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
- (2011) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
- (2011) B. Bao et al. CANCER RESEARCH
- Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study
- (2011) Suejung G. Kim et al. CLINICAL CANCER RESEARCH
- Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer
- (2011) Murali Mohan Yallapu et al. CURRENT DRUG METABOLISM
- Curcumin
- (2011) Mark G. Alexandrow et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms
- (2011) Xiaoxia Xie et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
- (2011) Reason Wilken et al. Molecular Cancer
- Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma
- (2011) Santosh S. Dhule et al. Nanomedicine-Nanotechnology Biology and Medicine
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells
- (2010) Ensaf M. Al-Hujaily et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
- (2010) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression
- (2010) W. Glienke et al. CANCER INVESTIGATION
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
- (2010) Marina Pisano et al. Molecular Cancer
- A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
- (2010) Li Lin et al. Molecular Cancer
- Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor- B Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/I B Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma
- (2010) Z.-J. Sun et al. MOLECULAR PHARMACOLOGY
- Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2010) Ron Epelbaum et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- RETRACTED: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers
- (2009) Sheeja T. Tharakan et al. BIOCHEMICAL PHARMACOLOGY
- Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressorTUP1inCandida albicans
- (2009) Monika Sharma et al. BIOSCIENCE REPORTS
- New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells
- (2009) Ling Cen et al. BMC CANCER
- Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo
- (2009) Hiroyuki Shibata et al. CANCER SCIENCE
- New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells
- (2009) Li Lin et al. CANCER SCIENCE
- Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
- (2009) J. Shaikh et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (BiocurcumaxTM), a novel bioenhanced preparation of curcumin
- (2009) B Antony et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model
- (2009) Ajaikumar B. Kunnumakkara et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines
- (2009) Tiffany J. Somers-Edgar et al. INVESTIGATIONAL NEW DRUGS
- Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin
- (2009) Makoto Takahashi et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells
- (2009) Maha H. Elamin et al. MOLECULAR CARCINOGENESIS
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer Cells
- (2008) G. Chadalapaka et al. CANCER RESEARCH
- Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[ a ]pyrene-treated mice: mechanism of its anti-initiating action
- (2008) Rachana Garg et al. CARCINOGENESIS
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Roles of estrogen receptor and in modulating urothelial cell proliferation
- (2008) J. Teng et al. ENDOCRINE-RELATED CANCER
- Curcumin Blocks the Activation of Androgen and Interlukin-6 on Prostate-Specific Antigen Expression in Human Prostatic Carcinoma Cells
- (2008) K.-H. Tsui et al. JOURNAL OF ANDROLOGY
- Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism
- (2008) S. Yu et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of I B Kinase-Nuclear Factor- B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
- (2008) A. L. Kasinski et al. MOLECULAR PHARMACOLOGY
- Anti cancer effects of curcumin: cycle of life and death
- (2008) Gaurisankar Sa et al. Cell Division
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now